Previous 10 | Next 10 |
IRVINE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a medical device company with a portfolio of products focused on enabling therapies for neurological disorders, today announced financial results for its third fiscal quarter ended September 30, 2020. ...
IRVINE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 third quarter, which ended September 30, 2020, on Tuesday, November 10, 2020 after the market close. The ...
Gainers: ReWalk Robotics (RWLK) +18%, Aldeyra Therapeutics (ALDX) +19%, ClearPoint Neuro (CLPT) +15%, ProPhase Labs (PRPH) +12%, Orchard Therapeutics (ORTX) +11%.Losers: Biomerica (BMRA) -20%, Adaptimmune Therapeutics (ADAP) -14%, Ca...
20 Gene Therapy Clinical Trials Using the ClearPoint platform. Utilizes Razor / Blades Business Model. Disposables and Biologics ("Blades") revenues up 183% in Q2 2020. Significant Operating Leverage: Past 5 Years SG&A up ~20% while Gross Profit was up Over 300%. Large...
ClearPoint Neuro (NASDAQ: CLPT ) has appointed Danilo D’Alessandro as the next Chief Financial Officer succeeding Harold A. Hurwitz who plans to retire in 2021. More news on: ClearPoint Neuro, Inc., Healthcare stocks news, Read more ...
IRVINE, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) is pleased to announce that global medical device financial executive Danilo D’Alessandro has been appointed the Company’s next Chief Financial Officer (CFO) succeeding Harold A. (Hal) Hur...
ClearPoint Neuro, Inc. (CLPT) Q2 2020 Results Conference Call August 12, 2020 4:30 PM ET Company Participants Joe Burnett - CEO Harold Hurwitz - CFO Conference Call Participants Sall Yanchus - Brookline Capital Markets Andrew D'Silva - B. Riley FBR Presentation Op...
ClearPoint Neuro (NASDAQ: CLPT ) : Q2 GAAP EPS of -$0.11 beats by $0.03 . More news on: ClearPoint Neuro, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its second fiscal quarter and six months ended June 30, 2020. Financial Results – Three Months Ended June 30, 2020 Total revenues for the quarter wer...
IRVINE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 second quarter, which ended June 30, 2020, on Wednesday, August 12, 2020 after the market close. The Comp...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...